Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Neuroscience Research to Benefit from 3-D Printing of Brain-Like Structures

By LabMedica International staff writers
Posted on 12 Aug 2015
Advanced three-dimensional printing techniques were used to generate a biological construct that incorporated neural cells and mimicked brain cell activities for use in applications ranging from cell behavior studies to improving understanding of brain injuries and neurodegenerative diseases.

Researchers have attempted to study the brain by modeling the architecture using two dimensional (2-D) in vitro cell culturing methods. More...
While those platforms attempt to mimic the in vivo environment, they do not truly resemble the three dimensional (3-D) microstructure of neuronal tissues. Development of an accurate in vitro model of the brain remains a significant obstacle to understanding the functioning of the brain at the tissue or organ level.

Investigators at the ARC Centre of Excellence for Electromaterials Science (North Wollongong, NSW, Australia) applied a 3-D printing approach to the problem of developing a useful in vitro brain model. They reported in the July 14, 2015, online edition of the journal Biomaterials that they had developed a new method to bioprint 3-D brain-like structures consisting of discrete layers of primary neural cells encapsulated in hydrogels.

Brain-like structures were constructed with a Stratasys Ltd. (Rehovot, Israel) Connex Objet350 3D printer using a bio-ink consisting of a novel peptide-modified biopolymer, gellan gum-RGD (RGD-GG), combined with primary cortical neurons. The ink was optimized for a modified reactive printing process and developed for use in traditional cell culturing facilities without the need for extensive bioprinting equipment. Furthermore, the peptide modification of the gellan gum hydrogel was found to have a profound positive effect on primary cell proliferation and network formation. Neural cell viability combined with the support of neural network formation demonstrated the cell supportive nature of the matrix.

"This study highlights the importance of integrating advances in 3-D printing, with those in materials science, to realize a biological outcome," said senior author Dr. Gordon Wallace, head of the ARC Centre of Excellence for Electromaterials Science.

"This paves the way for the use of more sophisticated printers to create structures with much finer resolution. We are still a long way from printing a brain but the ability to arrange cells so as they form neuronal networks is a significant step forward."

Related Links:

ARC Centre of Excellence for Electromaterials Science
Stratasys Ltd.



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.